Laws and sections by number or title, due dates, pages, and updates.
The Directorate General of Foreign Trade amends Standard Input Output Norms A-222 for the export of Erythromycin Stearate Tablet. The amendment updates the import item quantity for Erythromycin Stearate to 334 mg for 1 number tablet of Erythromycin Stearate tablets of 250 mg. Exporters use pro-rata calculations for other variants of export items. The change takes effect immediately.
What you must do
Key dates
Who is affected
Ask about this public notice
(TO BE PUBLISHED IN THE GAZETTE OF INDIA EXTRAORDINARY (PART-I (SECTION-1)
Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade
Public Notice No. 46 /2024-25 New Delhi, Dated 6th February, 2025
Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
| Export Product | Quantity | Sl. No. | Import Item/s | Quantity |
|---|---|---|---|---|
| Erythromycin Stearate tablets-250 mg. (each tablet contains erythromycin stearate equivalent to 250 mg. of Erythromycin | 1 Number Tablet | 1 | Erythromycin Stearate | 334 mg. |
Note: For other variants of export items, norms may be worked out on a pro-rata basis.
Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.
[Image omitted. See the official document.]
(Santosh Kumar Sarangi) Director General of Foreign Trade Ex-officio Addl. Secretary to the Government of India e-mail: dgft@nic.in
(Issued from File No. 01/82/0017/AM-25/DES-III)
